Authors: O'Donnell, RT DeNardo, SJ Yuan, A Shen, S Richman, CM Lara, PN Griffith, IJ Goldstein, DS Kukis, DL Martinez, GS Mirick, GR DeNardo, GL Meyers, FJ

Citation: Rt. O'Donnell et al., Radioimmunotherapy with In-111/Y-90-2IT-BAD-m170 for metastatic prostate cancer, CLIN CANC R, 7(6), 2001, pp. 1561-1568

Authors: Richman, CM Denardo, SJ

Citation: Cm. Richman et Sj. Denardo, Systemic radiotherapy in metastatic breast cancer using Y-90-linked monoclonal MUC-1 antibodies, CR R ONC H, 38(1), 2001, pp. 25-35

Authors: DeNardo, GL O'Donnell, RT Kroger, LA Richman, CM Goldstein, DS Shen, S DeNardo, SJ

Citation: Gl. Denardo et al., Strategies for developing effective radioimmunotherapy for solid tumors, CLIN CANC R, 5(10), 1999, pp. 3219S-3223S

Authors: Richman, CM DeNardo, SJ O'Donnell, RT Goldstein, DS Shen, S Kukis, DL Kroger, LA Yuan, A Boniface, GR Griffith, IJ DeNardo, GL

Citation: Cm. Richman et al., Dosimetry-based therapy in metastatic breast cancer patients using Y-90 monoclonal antibody 170H.82 with autologous stem cell support and cyclosporina, CLIN CANC R, 5(10), 1999, pp. 3243S-3248S

Authors: Denardo, SJ Richman, CM Kukis, DL Shen, S Lamborn, KR Miers, LA Kroger, LA Perez, EA DeNardo, GL

Citation: Sj. Denardo et al., Synergistic therapy of breast cancer with Y-90-chimeric L6 and paclitaxel in the xenografted mouse model: Development of a clinical protocol, ANTICANC R, 18(6A), 1998, pp. 4011-4018